La plateforme OSKAR Bordeaux évolue pour rejoindre l'archive ouverte HAL. Retrouvez tous vos dépôts sur le nouveau portail HAL UB : https://u-bordeaux.hal.science/. Pour toute aide ou information, contactez-nous info@oskar-bordeaux.fr
Navigation Neurocentre Magendie - U1215 par Auteur "PAPEIX, Caroline"
Voici les éléments 1-8 de 8
-
Serum Neurofilament Levels and PML Risk in Patients With Multiple Sclerosis Treated With Natalizumab
(Neurology. vol. 8, n° 4, 2021-04-26)Article de revueLibre accès
-
Rituximab De-escalation in Patients With Neuromyelitis Optica Spectrum Disorder
(Neurology. vol. 101, n° 4, pp. E438-E450, 2023-07-25)Article de revue -
Highly Effective Therapies as First-Line Treatment for Pediatric-Onset Multiple Sclerosis
(JAMA neurology. vol. 81, n° 3, pp. 273-282, 2024-03-01)Article de revueLibre accès
-
Anti-CD20 Therapies in Drug-Naive Patients With Primary Progressive Multiple Sclerosis
(Neurology. vol. 103, n° 8, pp. e209886, 2024-10-22)Article de revue -
Investigating the Long-term Effect of Pregnancy on the Course of Multiple Sclerosis Using Causal Inference.
(Neurology. vol. 100, n° 12, pp. e1296-e1308, 2023-03-21)Article de revueLibre accès
-
Acute Clinical Events Identified as Relapses With Stable Magnetic Resonance Imaging in Multiple Sclerosis
(JAMA neurology. vol. 81, n° 8, pp. 814-823, 2024-08)Article de revue -
Advocating for rituximab as first-line treatment for NMOSD-AQP4 patients in France: Cost and efficacy considerations
(Revue Neurologique. vol. 180, n° 8, pp. 711-714, 2024-10)Article de revue -
Early Maintenance Treatment Initiation and Relapse Risk Mitigation After a First Event of MOGAD in Adults
(Neurology. vol. 103, n° 3, pp. e209624, 2024-08-13)Article de revue